Laschet, C., Dupuis, N., Hanson, J., The G protein-coupled receptors deorphanization landscape. Biochem. Pharmacol. 153 (2018), 62–74.
De, A., Veulens, N., Rodríguez, R., G Protein-coupled receptors as targets for drug design. Biotecnol. Apl. 26 (2009), 24–33.
Matsumoto, M., Saito, T., Takasaki, J., Kamohara, M., Sugimoto, T., Kobayashi, M., Tadokoro, M., Matsumoto, S., Ohishi, T., Furuichi, K., An evolutionarily conserved G-protein coupled receptor family, SREB, Expressed in the Central Nervous System. Biochem. Biophys. Res. Commun. 272 (2000), 576–582.
Fredriksson, R., Lagerström, M.C., Lundin, L.G., Schiöth, H.B., The G-proteincoupled receptors in the human genome form five main families: phylogenetic analysis, paralogon groups, and fingerprints. Mol. Pharmacol. 63 (2003), 1256–1272.
Regard, J.B., Sato, I.T., Coughlin, S.R., Anatomical profiling of G protein-coupled receptor expression. Cell 135 (2008), 561–571.
Hellebrand, S., Wittenberger, T., Schaller, H.C., Hermans-Borgmeyer, I., GPR85, a novel member of the G-protein coupled receptor family, prominently expressed in the developing mouse cerebral cortex. Brain Res. Gene Expr. Patterns 1 (2001), 13–16.
Ku, G.M., Pappalardo, Z., Luo, C.C., German, M.S., McManus, M.T., An siRNA screen in pancreatic beta cells reveals a role for GPR27 in insulin production. PLoS Genet., 8, 2012, e1002449.
Chopra, D.G., Yiv, N., Hennings, T.G., Zhang, Y., Ku, G.M., Deletion of GPR27 in vivo reduces insulin mRNA but does not result in diabetes. Sci. Rep., 10, 2020, 5629.
Nath, A.K., Ma, J., Chen, Z.Z., Li, Z., Vitery, M.D.C., Kelley, M.L., Peterson, R.T., Gerszten, R.E., Yeh, J.J., Genetic deletion of GPR27 alters acylcarnitine metabolism, insulin sensitivity, and glucose homeostasis in zebrafish. Faseb. J. 34 (2020), 1546–1557.
Dupuis, N., Laschet, C., Franssen, D., Szpakowska, M., Gilissen, J., Geubelle, P., Soni, A., Parent, A.S., Pirotte, B., Chevigné, A., Twizere, J. Cl, Hanson, J., Activation of the orphan G protein-coupled receptor GPR27 by surrogate ligands promotes β -arrestin 2 recruitment. Mol. Pharmacol. 91 (2017), 595–608.
Kroeze, W.K., Sassano, M.F., Huang, X.P., Lansu, K., McCorvy, J.D., Giguère, P.M., Sciaky, N., Roth, B.L., PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome. Nat. Struct. Mol. Biol. 22 (2015), 362–369.
Yanai, T., Kurosawa, A., Nikaido, Y., Nakajima, N., Saito, T., Osada, H., Konno, A., Hirai, H., Takeda, S., Identification and molecular docking studies for novel inverse agonists of SREB, super conserved receptor expressed in brain. Gene Cell. 21 (2016), 717–772.
Ge, S., Zhong, H., Ma, X., Zheng, Y., Zou, Y., Wang, F., Wang, Y., Hu, Y., Li, Y., Liu, W., Guo, W., Xu, Q., Lai, Y., Discovery of secondary sulphonamides as Ido1 inhibitors with potent antitumour effects in vivo. J. Enzym. Inhib. Med. Chem. 35 (2020), 1240–1257.
Xu, F., Zhao, Y., Zhou, H., Li, C., Zhang, X., Hou, T., Qu, L., Wei, L., Wang, J., Liu, Y., Liang, X., Synthesis and evaluation of 3-(4-(phenoxymethyl)phenyl)propanoic acid and N-phenylbenzenesulfonamide derivatives as FFA4 agonists. Bioorg. Med. Chem. Lett, 30, 2020, 127650.
Silveira, F.F., de Souza, J.O., Hoelz, L.V.B., Campos, V.R., Jabor, V.A.P., Aguiar, A.C.C., Nonato, M.C., Albuquerque, M.G., Guido, R.V.C., Boechat, N., Pinheiro, L.C.S., Comparative study between the anti-P. falciparum activity of triazolopyrimidine, pyrazolopyrimidine and quinoline derivatives and the identification of new PfDHODH inhibitors. Eur. J. Med. Chem., 209, 2021, 112941.
Batra, N., Rajendran, V., Agarwal, D., Wadi, I., Ghosh, P.C., Gupta, R.D., Nath, M., Synthesis and antimalarial evaluation of [1,2,3]-triazole-tethered sulfonamide-berberine hybrids. ChemistrySelect 3 (2018), 9790–9793.
Franco, F.M., Jones, D.E., Harris, P.K., Han, Z., Wildman, S.A., Jarvis, C.M., Janetka, J.W., Structure-based discovery of small molecule hepsin and HGFA protease inhibitors: evaluation of potency and selectivity derived from distinct binding pockets Bioorg. Med. Chem. 23 (2015), 2328–2343.
Boechat, N., Carvalho, R.C.C., Ferreira, M.L.G., Coutinho, J.P., Sa, P.M., Seito, L.N., Rosas, E.C., Krettli, A.U., Bastos, M.M., Pinheiro, L.C.S., Comparative study between the anti-P. falciparum activity of triazolopyrimidine, pyrazolopyrimidine and quinoline derivatives and the identification of new PfDHODH inhibitors. Bioorg. Med. Chem., 28, 2020, 115832.
Uysal, S., Soyer, Z., Saylam, M., Tarikogullari, A.H., Yilmaz, S., Kirmizibayrak, P.B., Design, synthesis and biological evaluation of novel naphthoquinone-4-aminobenzensulfonamide/carboxamide derivatives as proteasome inhibitors. Eur. J. Med. Chem., 209, 2021, 112890.
Turcotte, V., Fortin, S., Vevey, F., Coulombe, Y., Lacroix, J., Côté, M.F., Masson, J.Y.C.-G.R., Synthesis, biological evaluation, and structure-activity relationships of novel substituted N-phenylureidobenzenesulfonate derivatives blocking cell cycle progression in S-phase and inducing DNA double-strand breaks. J. Med. Chem. 55 (2012), 6194–6208.
Zhang, F., Du, J., Wang, Q., Hu, Q., Zhang, J., Ding, D., Zhao, Y., Yang, F., Wang, E., Zhou, H., Discovery of N-(4-sulfamoylphenyl)thioureas as Trypanosoma brucei leucyl-tRNA synthetase inhibitors. Org. Biomol. Chem. 11 (2013), 5310–5324.
Wang, L., Li, L., Zhou, Z.H., Jiang, Z.Y., You, Q.D., Xu, X.L., Structure-based virtual screening and optimization of modulators targeting Hsp90-Cdc37 interaction. Eur. J. Med. Chem. 136 (2017), 63–73.
Qandil, A.M., Hassan, M.A., Al-Shar'I, N.A., Synthesis and anticandidal activity of azole-containing sulfonamides. Arch. Pharm (Weinheim) 341 (2008), 99–112.
Sastry, G.M., Dixon, S.L., Sherman, W., Rapid shape-based ligand alignment and virtual screening method based on atom/feature-pair similarities and volume overlap scoring. J. Chem. Inf. Model. 51 (2011), 2455–2466.
Friesner, R.A., Murphy, R.B., Repasky, M.P., Frye, L.L., Greenwood, J.R., Halgren, T.A., Sanschagrin, P.C., Mainz, D.T., Extra Precision Glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein−ligand complexes. J. Med. Chem. 49 (2006), 6177–6196.
Sherman, W., Day, T., Jacobson, M.P., Friesner, R.A., Farid, R., Novel procedure for modeling ligand/receptor induced fit effects. J. Med. Chem. 49 (2006), 534–553.
Jacobson, M.P., Pincus, D.L., Rapp, C.S., Day, T.J.F., Honig, B., Shaw, D.E., Friesner, R.A., A hierarchical approach to all-atom protein loop prediction. Proteins 55 (2004), 351–367.
Huang, N., Kalyanaraman, C., Irwin, J.J., Jacobson, M.P., Physics-based scoring of protein-ligand complexes: enrichment of known inhibitors in large-scale virtual screening. J. Chem. Inf. Model. 46 (2006), 243–253.
Abel, R., Young, T., Farid, R., Berne, B.J., Friesner, R.A., Role of the active-site solvent in the thermodynamics of factor Xa ligand binding. J. Am. Chem. Soc. 130 (2008), 2817–2831.
